PH12920A - Composition and method for treatment of hepatic diseases and mental fatigue - Google Patents
Composition and method for treatment of hepatic diseases and mental fatigueInfo
- Publication number
- PH12920A PH12920A PH12897A PH12897A PH12920A PH 12920 A PH12920 A PH 12920A PH 12897 A PH12897 A PH 12897A PH 12897 A PH12897 A PH 12897A PH 12920 A PH12920 A PH 12920A
- Authority
- PH
- Philippines
- Prior art keywords
- treatment
- composition
- mental fatigue
- hepatic diseases
- hepatic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8093670A | 1970-10-15 | 1970-10-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12920A true PH12920A (en) | 1979-10-10 |
Family
ID=22160611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12897A PH12920A (en) | 1970-10-15 | 1971-10-05 | Composition and method for treatment of hepatic diseases and mental fatigue |
Country Status (9)
| Country | Link |
|---|---|
| AU (1) | AU3460571A (en) |
| BE (1) | BE773910A (en) |
| DE (1) | DE2150900A1 (en) |
| FR (1) | FR2110465A1 (en) |
| GB (1) | GB1310658A (en) |
| IL (1) | IL37904A0 (en) |
| NL (1) | NL7114199A (en) |
| PH (1) | PH12920A (en) |
| ZA (1) | ZA716628B (en) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0059775B1 (en) * | 1980-06-09 | 1984-09-19 | Leopold & Co. Chem. pharm. Fabrik Gesellschaft m.b.H. | Infusion solution for the protection of the liver and the improvement of its functioning, and process for its production |
| GB2199243A (en) * | 1986-09-17 | 1988-07-06 | Natural Vitality Ltd | Pharmaceutical compositions comprising ornithine and arginine |
| EP0318891B1 (en) * | 1987-12-04 | 1992-01-02 | ASTA Medica Aktiengesellschaft | Injectable solution of thioctic acid containing trometamole and/or basic amino acids |
| AT500684B8 (en) * | 1989-11-09 | 2006-11-15 | Meda Pharma Gmbh & Co Kg | USE OF SWEAT CARBOXYLIC ACIDS FOR THE MANUFACTURE OF A MEDICAMENT FOR COMBATING DISEASES OF RETROVIRUSES |
| FR2791571B1 (en) * | 1999-04-02 | 2002-10-04 | Sod Conseils Rech Applic | ASSOCIATION OF NO SYNTHASE INHIBITOR (S) AND METABOLIC ANTIOXIDANT (S) |
| US6346382B1 (en) * | 1999-06-01 | 2002-02-12 | Vanderbilt University | Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto |
| US9486429B2 (en) | 1999-06-01 | 2016-11-08 | Vanderbilt University | Therapeutic methods employing nitric oxide precursors |
| CZ20022927A3 (en) * | 2000-02-01 | 2003-06-18 | Muscletech Research And Development Inc. | Food supplements based on alpha-lipoic acid for increasing pure muscle mass and strength |
| JP3907964B2 (en) * | 2001-04-25 | 2007-04-18 | 株式会社 伊藤園 | Mental fatigue reducing composition, concentration maintenance enhancing composition and mental vitality maintenance enhancing composition |
| KR20050009718A (en) * | 2002-05-29 | 2005-01-25 | 유니레버 엔.브이. | Odor control in amine salt containing cosmetic composition |
| SI2153870T1 (en) | 2004-11-26 | 2014-05-30 | Ucl Business Plc | Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy |
| CN101282721B (en) * | 2005-10-04 | 2013-05-01 | 协和发酵生化株式会社 | Composition for relieving subjective symptoms of fatigue |
| ATE508740T1 (en) * | 2006-06-07 | 2011-05-15 | Kyowa Hakko Bio Co Ltd | AGENTS FOR REDUCING FATIGUE |
| US8945655B2 (en) | 2007-07-10 | 2015-02-03 | Conopco, Inc. | Stable and consumable compositions |
| JP5623916B2 (en) | 2008-01-31 | 2014-11-12 | バンダービルト・ユニバーシティＶａｎｄｅｒｂｉｌｔ Ｕｎｉｖｅｒｓｉｔｙ | Pharmaceutical composition for aneurysmal subarachnoid hemorrhage and vasospasm |
| HUE035921T2 (en) | 2009-04-03 | 2018-05-28 | Ocera Therapeutics Inc | L-Ornithine Phenylacetate and Methods of Preparation |
| CN104434894A (en) | 2009-06-08 | 2015-03-25 | Ucl商业有限公司 | Reatment of portal hypertension using l-ornithine phenylacetate |
| US8946473B2 (en) | 2010-10-06 | 2015-02-03 | Ocera Therapeutics, Inc. | Methods of making L-ornithine phenyl acetate |
| ES2769000T3 (en) | 2014-11-24 | 2020-06-24 | Ucl Business Ltd | Treatment of diseases associated with the activation of liver stellate cells using ammonia-reducing therapies |
| WO2017031131A1 (en) | 2015-08-18 | 2017-02-23 | Ocera Therapeutics, Inc. | Treatment and prevention of muscle loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrate |
| MX389665B (en) | 2017-05-11 | 2025-03-20 | Ocera Therapeutics Inc | PROCESSES FOR PRODUCING L-ORNITHINE PHENYLACETATE |
-
1971
- 1971-10-04 ZA ZA716628A patent/ZA716628B/en unknown
- 1971-10-05 PH PH12897A patent/PH12920A/en unknown
- 1971-10-07 GB GB4677271A patent/GB1310658A/en not_active Expired
- 1971-10-12 IL IL37904A patent/IL37904A0/en unknown
- 1971-10-13 BE BE773910A patent/BE773910A/en unknown
- 1971-10-13 DE DE19712150900 patent/DE2150900A1/en active Pending
- 1971-10-14 AU AU34605/71A patent/AU3460571A/en not_active Expired
- 1971-10-15 NL NL7114199A patent/NL7114199A/xx unknown
- 1971-10-15 FR FR7137199A patent/FR2110465A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| DE2150900A1 (en) | 1972-04-20 |
| GB1310658A (en) | 1973-03-21 |
| BE773910A (en) | 1972-01-31 |
| FR2110465A1 (en) | 1972-06-02 |
| NL7114199A (en) | 1972-04-18 |
| IL37904A0 (en) | 1971-12-29 |
| AU3460571A (en) | 1973-04-19 |
| ZA716628B (en) | 1972-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL37904A0 (en) | Composition and method for treatment of hepatic diseases and mental fatigue | |
| ZA718284B (en) | Method and apparatus for the continuous treatment of fibrous materials | |
| IL37098A0 (en) | Skin treatment composition and its preparation | |
| PH10336A (en) | Nono-chromone-2-carboxylic acid and method and composition for the treatment of asthma | |
| IL36045A0 (en) | New pregnane derivative and process of preparation | |
| IL36021A (en) | Process and apparatus for the continuous treatment of threads | |
| ZA728566B (en) | Method and compositions for the treatment of human hair | |
| CS190371B2 (en) | Means for destroying the phytopatogenous organism and method of making the active agents | |
| ZA713249B (en) | Therapeutic process and compositions | |
| ZA713073B (en) | Anthelmintic composition and method of use | |
| BE765352A (en) | METHOD AND COMPOSITION FOR THE TREATMENT OF | |
| IL37953A0 (en) | Substituted oxazepines and method of use | |
| AU458749B2 (en) | Process for the treatment and care of dentures | |
| PH12038A (en) | Composition containing cyclobenzaprine for use in the treatment of skeletal muscle disorders and method of treatmen | |
| AU464700B2 (en) | Composition and method of treatment | |
| AU462834B2 (en) | Pharmaceutical composition and method of treatment | |
| BE774917A (en) | COMPOSITION FOR THE TREATMENT OF THE HAIR AND METHOD FOR PREPARING THIS COMPOSITION | |
| CH537160A (en) | Equipment for fermentation and / or heat treatment of tobacco | |
| IL37923A0 (en) | Process for the treatment of dentures with silicon oil | |
| IE35467B1 (en) | Treatment of fats and oils | |
| CA837050A (en) | Method of and composition for the treatment of human carcinoma and hypercholestrolemia | |
| ZA708706B (en) | Antheilmintic composition and method of use | |
| ZA711821B (en) | Pharmaceutical compositions and methods of treatment | |
| ZA71461B (en) | Method of treating parkinson's disease | |
| ZA714297B (en) | Process for the treatment of woollen material and blends thereof |